How did ResMed's revenue and expenses trend in Q2 2025?

ResMed's revenue for Q2 2025 was $1.07 billion, with significant contributions from the Sleep and Respiratory Care segment ($1.07 billion), Devices segment ($625.79 million), Masks and Other segment ($441.95 million), and Software As a Service and Software Service segments ($156.77 million each). The Amortization of acquired intangible assets segment contributed $0.

The Cost of Goods Sold for Q2 2025 was $530.81 million. This indicates the direct costs associated with generating revenue, which, when compared to the revenue figures, suggests a healthy gross profit margin for the period.

ResMed's Research and Development Expenses were $81.37 million, reflecting the company's investment in innovation and product development. This expense is crucial for maintaining a competitive edge in the healthcare technology sector.

Selling, General, and Administrative Expenses were $252.66 million. These expenses are essential for commercial and administrative activities, ensuring the smooth functioning of the business.

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|RMD|RMD.N|ResMed|20250101-2025|Amortization of acquired intangible assets|0|169|
|RMD|RMD.N|ResMed|20250101-2025|Amortization of acquired intangible assets|0|169|

|code|Ticker|Name|Date|Cost of Goods Sold|Cost of Goods Sold YoY|market_code|
|---|---|---|---|---|---|---|
|RMD|RMD.N|ResMed|2024 Q3|5.04199E8|1.012329058031117|169|
|RMD|RMD.N|ResMed|2024 Q4|5.07668E8|0.5940515584441318|169|
|RMD|RMD.N|ResMed|2025 Q1|5.0729E8|1.0012722468995203|169|
|RMD|RMD.N|ResMed|2025 Q2|5.30814E8|2.897452250289319|169|

|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|RMD|RMD.N|ResMed|2024 Q3|7.7074E7|0.8346852268564551|169|
|RMD|RMD.N|ResMed|2024 Q4|8.0861E7|3.476914414414414|169|
|RMD|RMD.N|ResMed|2025 Q1|7.9524E7|5.037643640206049|169|
|RMD|RMD.N|ResMed|2025 Q2|8.1372E7|10.14076881429345|169|

|code|Ticker|Name|Date|Selling, General, and Administrative Expenses|Selling, General, and Administrative Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|RMD|RMD.N|ResMed|20240930|2.41123E8|0.1986328409067298|169|
|RMD|RMD.N|ResMed|20241231|2.5345E8|0.1758858520582597|169|
|RMD|RMD.N|ResMed|20250331|2.50383E8|6.386151865495659|169|
|RMD|RMD.N|ResMed|20250630|2.5266E8|8.098163708863144|169|